San Francisco-based AliveCor,Inc. recently announced that the U.S. Food and Drug Administration (FDA) granted the company clearance for two new algorithms for its Smart Phone-based ECG device, the ...

Earlier this year, AliveCor, Inc., a medical device and AI company producing electrocardiogram (ECG) hardware and software for consumer mobile devices, succeeded in convincing an International Trade ...

Apple faces potential smartwatch import ban over AliveCor patent claims PTO tribunal finds patents invalid week before scheduled ITC decision on ban (Reuters) - A U.S. Patent and Trademark Office ...

SAN FRANCISCO--(BUSINESS WIRE)--AliveCor, Inc., a premier digital health company, announced today that its Heart Monitor is now available for the iPhone 5, joining the current models for the iPhone 4 ...

AliveCor, Inc. announced today the launch of the latest version of the AliveECG app, with two new FDA-cleared and CE-marked automated detectors that allow patients and physicians to focus on the ECGs ...

SAN FRANCISCO--(BUSINESS WIRE)--AliveCor, Inc. announced today at the start of the 4th annual mHealth Summit in Washington, D.C. that the company received FDA 510(k) clearance on its mobile Heart ...

VANCOUVER, British Columbia--(BUSINESS WIRE)-- WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health ...

Feb 6 (Reuters) - Apple (AAPL.O), opens new tab persuaded a federal judge to dismiss a lawsuit by a Silicon Valley startup accusing it of illegally monopolizing the U.S. market for heart rate ...

Silicon Valley-based AliveCor, which uses artificial intelligence to improve cardiac care, has secured a $20 million loan from Oxford Finance LLC. The capital will be used to provide additional ...

AliveCor, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial fibrillation (AFib), the most common form of ...

Atrial fibrillation (AF) continues to be the most common heart rhythm disturbance, affecting more than 140 million people worldwide. AliveCor is focused on helping those with diagnosed and undiagnosed ...